Evidence map›Paper›PMID 34234569›Full record

ArticleClinical epidemiology2021

Burden of Respiratory Infection and Tuberculosis Among US States from 1990 to 2019.

Wen Zhong, Nicola Luigi Bragazzi, Jude Dzevela Kong, Saeid Safiri, Masoud Behzadifar, Jun Liu, Xinyao Liu, Weijun Wang

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. How Much Does the United States Spend on Respiratory Diseases?American journal of respiratory and critical care medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Wen ZhongDepartment of General Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.ORCID 0000-0002-2444-3047
Nicola Luigi BragazziCentre for Disease Modelling, York University, Toronto, Ontario, Canada.
Jude Dzevela KongCentre for Disease Modelling, York University, Toronto, Ontario, Canada.
Saeid SafiriTuberculosis and Lung Disease Research Center, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0001-7986-9072
Masoud BehzadifarSocial Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.ORCID 0000-0002-0271-4360
Jun LiuDepartment of General Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Xinyao LiuDepartment of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.ORCID 0000-0002-2454-7436
Weijun WangUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Central South University · CNYork University · CALorestan University of Medical Sciences · IRTabriz University of Medical Sciences · IRUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo estimate the incidence, death, disability-adjusted life years (DALYs) and attributable risk factors for respiratory infection and tuberculosis (RIT) in the US from 1990 to 2019.

methodsFollowing the methodology framework and analytical strategies used in the Global Burden of Disease Study 2019, the incidence, death, DALYs and risk factors of RIT were examined by age, gender and states from 1990 to 2019 in the US. All estimates were calculated as counts, age-standardized rates per 100,000 people and percentage change, with 95% confidence intervals (CIs).

resultsIn 2019, the age-standardized incidence, death and DALY rates per 100,000 people of RIT were 339,703 (95% CI 303,184 to 382,354), 13.6 (95% CI 12.2 to 14.4) and 384.9 (95% CI 330.6 to 458.6), respectively. Among RIT causes, upper respiratory infection accounted for the large majority of RIT age-standardized incidence rate, while lower respiratory infection constituted the highest proportion of RIT age-standardized death and DALY rates. The age-standardized incidence, death and DALY rates of RIT in 2019 and their temporal trends since 1990 varied widely across states and socio-demographic index. Among all attributable risk factors, smoking was the leading one for age-standardized RIT deaths in 2019, followed by low temperature and alcohol use (the attributable fractions were 17.7%, 15.3% and 6.9%, respectively).

conclusionOur results suggest that RIT remained a major cause of health burden in the US, with large disparities persisting between US states. Intervention efforts for RIT hotspots, high-risk populations and modifiable risk factors are necessary.

Indexed as

disability-adjusted life yearsmortalitytrendUnited States

Identifiers

PMID34234569
PMCPMC8254524
OpenAlexW3177050212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.